Lee Ainslie

Last Update: 02-17-2015

Number of Stocks: 45
Number of New Stocks: 12

Total Value: $6,381 Mil
Q/Q Turnover: 26%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Lee Ainslie Watch

  • Larry Robbins' Top Growth Stocks

    Glenview Capital Management, founded in 2000 by Larry Robbins (Trades, Portfolio), is a privately held investment management firm. In its 14th year of operation, Glenview manages approximately $7.4B of assets split between two products: the Glenview Funds (long/short) and the Glenview Opportunity Funds (concentrated, opportunistic). Since inception, the compounded annualized rates of return for the Glenview and GO Funds are approximately 15% and 25%, respectively (through January 2014). Glenview is focused on delivering attractive absolute returns through an intense focus on deep fundamental research and individual security selection. Their investments are primarily focused on the US, with a smaller amount of exposure in Western Europe.  

  • Guru Lee Ainslie Buys Stake in Google in Fourth Quarter

    Guru Lee Ainslie (Trades, Portfolio)’s quarterly investment activity is worth observing.

    Ainslie founded Dallas-based Maverick Capital with $38 million in 1993. Today, it is worth $10 billion. He also learned from Julian Robertson (Trades, Portfolio) at Tiger Management so he has plenty of knowledge and experience. In addition to that, though, he has the input of six industry experts employed at Maverick Capital with whom he consults on a daily basis.


  • Matthews Pacific Tiger Fund Purchases Yum! Brands During Q4

    The Matthews Pacific Tiger Fund (Trades, Portfolio) invests at least 80% of its total assets in the Asia region except Japan. As of Dec. 31, the fund had $8.1 billion in assets under management.

    The fund’s portfolio manager is Sharat Shroff, who joined Matthews in 2005 as a research analyst. Shroff also co-manages Matthews’ India, Asia Growth and Asia Focus strategies.


  • Why Soros, Burbank and Cohen Bought this Fairly Valued Stock

    In this article, let's take a look at Anheuser-Busch InBev SA/NV(BUD), a $184.78 billion market cap company that is a brewing company and manages a portfolio of over 200 brands of beer.

    Good dividend yield


  • Ainslie Lives Up to Reputation for Favoring Technology Stocks

    Value investor Lee Ainslie (Trades, Portfolio), the founder and CEO of Dallas-based hedge fund Maverick Capital Management LP, is known for investing in technology stocks. In the third quarter, he bought or sold stock in more than 50 companies, and many were in the technology sector – or, at least, mass media.

    Since its inception more than 20 years ago, Maverick Capital Management has had an average annual return of 11.2%.


  • Investors Could Triple Their Investments in AbbVie

    In this article, let´s consider AbbVie Inc. (ABBV), a $97.38 billion market cap company that is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories.

    Key drivers


  • Stocks Both Insiders and Gurus Are Buying

    The rule of thumb to only invest in companies you understand is one that shouldn’t be ignored. When an investor is familiar with a company or industry, there’s no better way to solidify the choice than to see whether shares are bought by those who understand the company best — the CEO, CFO and other executives, otherwise known as insiders.

    Using GuruFocus’ All-in-One Screener, I searched for stocks whose insiders have bought at least 10,000 shares, and have at least one guru who has purchased shares in the past two weeks.


  • Caxton Associates Bought this Stock

    In this article, let´s consider Anheuser-Busch InBev SA/NV (BUD), a $180.02 billion market cap. which has a trailing P/E ratio that indicates that the stock is relatively undervalued (PE 21.9x vs Industry Median 24.8x).

    So in this article, let's take a look at a model which is applicable to stable, mature, dividend-paying firms and try to find the intrinsic value of the stock. Although the model has a number of characteristics that make it useful and appropriate for many applications, it is by no means the be-all and end-all for valuation. The purpose is to force investors to evaluate different assumptions about growth and future prospects.


  • I Am Sure This Pharma-Company Suits Your Portfolio

    In this article, let's take a look at AbbVie Inc. (ABBV), a $15.85 billion market cap company, which is a global research-based pharmaceuticals business that emerged as a separate entity following its spin-off from Abbott Laboratories.



  • Why Ralph Lauren Should Be In Your Portfolio?

    In this article, let's take a look at Ralph Lauren Corporation (RL), a $13.87 billion market cap company, which designs, markets and distributes men's and women's apparel, accessories, fine watches and jewelry as well as other premium lifestyle products.

    Reasons to Buy


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)